| Acinetobacter baumannii |
Acinetobacter baumannii |
MIC |
25.0 |
ug.mL-1 |
10.1016/j.bmcl.2018.07.018 |
| Bacteroides caccae |
Bacteroides caccae |
Activity |
30.0 |
% |
10.1128/aac.00355-08 |
| Bacteroides caccae |
Bacteroides caccae |
Activity |
44.0 |
% |
10.1128/aac.00355-08 |
| Bacteroides caccae |
Bacteroides caccae |
MIC |
4.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Bacteroides caccae |
Bacteroides caccae |
MIC50 |
32.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Bacteroides caccae |
Bacteroides caccae |
MIC90 |
128.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Bacteroides fragilis |
Bacteroides fragilis |
Activity |
13.0 |
% |
10.1128/aac.00355-08 |
| Bacteroides fragilis |
Bacteroides fragilis |
Activity |
72.0 |
% |
10.1128/aac.00355-08 |
| Bacteroides fragilis |
Bacteroides fragilis |
MIC |
2.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Bacteroides fragilis |
Bacteroides fragilis |
MIC50 |
16.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Bacteroides fragilis |
Bacteroides fragilis |
MIC90 |
64.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Bacteroides thetaiotaomicron |
Bacteroides thetaiotaomicron |
Activity |
17.0 |
% |
10.1128/aac.00355-08 |
| Bacteroides thetaiotaomicron |
Bacteroides thetaiotaomicron |
Activity |
20.0 |
% |
10.1128/aac.00355-08 |
| Bacteroides thetaiotaomicron |
Bacteroides thetaiotaomicron |
MIC |
8.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Bacteroides thetaiotaomicron |
Bacteroides thetaiotaomicron |
MIC50 |
32.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Bacteroides thetaiotaomicron |
Bacteroides thetaiotaomicron |
MIC90 |
64.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Bacteroides uniformis |
Bacteroides uniformis |
Activity |
30.0 |
% |
10.1128/aac.00355-08 |
| Bacteroides uniformis |
Bacteroides uniformis |
Activity |
44.0 |
% |
10.1128/aac.00355-08 |
| Bacteroides uniformis |
Bacteroides uniformis |
MIC |
4.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Bacteroides uniformis |
Bacteroides uniformis |
MIC50 |
32.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Bacteroides uniformis |
Bacteroides uniformis |
MIC90 |
128.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Bos taurus |
Progesterone receptor |
IC50 |
nan |
None |
None |
| Bos taurus |
Progesterone receptor |
Ki |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Citrobacter freundii |
Citrobacter freundii |
MIC |
512.0 |
ug.mL-1 |
10.1128/aac.01337-07 |
| Clostridium paraputrificum |
Clostridium paraputrificum |
Activity |
0.0 |
% |
10.1128/aac.00355-08 |
| Clostridium paraputrificum |
Clostridium paraputrificum |
Activity |
89.0 |
% |
10.1128/aac.00355-08 |
| Clostridium paraputrificum |
Clostridium paraputrificum |
MIC |
0.12 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Clostridium paraputrificum |
Clostridium paraputrificum |
MIC50 |
1.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Clostridium paraputrificum |
Clostridium paraputrificum |
MIC90 |
16.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Clostridium perfringens |
Clostridium perfringens |
Activity |
0.0 |
% |
10.1128/aac.00355-08 |
| Clostridium perfringens |
Clostridium perfringens |
Activity |
89.0 |
% |
10.1128/aac.00355-08 |
| Clostridium perfringens |
Clostridium perfringens |
MIC |
0.12 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Clostridium perfringens |
Clostridium perfringens |
MIC50 |
1.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Clostridium perfringens |
Clostridium perfringens |
MIC90 |
16.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Clostridium septicum |
Clostridium septicum |
Activity |
0.0 |
% |
10.1128/aac.00355-08 |
| Clostridium septicum |
Clostridium septicum |
Activity |
89.0 |
% |
10.1128/aac.00355-08 |
| Clostridium septicum |
Clostridium septicum |
MIC |
0.12 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Clostridium septicum |
Clostridium septicum |
MIC50 |
1.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Clostridium septicum |
Clostridium septicum |
MIC90 |
16.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Clostridium tertium |
Clostridium tertium |
Activity |
0.0 |
% |
10.1128/aac.00355-08 |
| Clostridium tertium |
Clostridium tertium |
Activity |
89.0 |
% |
10.1128/aac.00355-08 |
| Clostridium tertium |
Clostridium tertium |
MIC |
0.12 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Clostridium tertium |
Clostridium tertium |
MIC50 |
1.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Clostridium tertium |
Clostridium tertium |
MIC90 |
16.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Escherichia coli |
Escherichia coli |
MIC |
0.05 |
ug.mL-1 |
10.1016/j.ejmech.2012.03.008 |
| Escherichia coli |
Escherichia coli |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.01337-07 |
| Escherichia coli |
Escherichia coli |
MIC |
0.39 |
ug.mL-1 |
10.1016/j.bmcl.2018.07.018 |
| Escherichia coli |
Escherichia coli |
MIC |
0.5 |
ug.mL-1 |
10.1128/aac.00227-08 |
| Escherichia coli |
Escherichia coli |
MIC |
0.5 |
ug.mL-1 |
10.1128/aac.01337-07 |
| Escherichia coli |
Escherichia coli |
MIC |
0.78 |
ug.mL-1 |
10.1016/j.bmcl.2018.07.018 |
| Escherichia coli |
Escherichia coli |
MIC |
1.0 |
ug.mL-1 |
10.1128/aac.00227-08 |
| Escherichia coli |
Escherichia coli |
MIC |
1.56 |
ug.mL-1 |
10.1016/j.bmcl.2018.07.018 |
| Escherichia coli |
Escherichia coli |
MIC |
6.25 |
ug.mL-1 |
10.1016/j.bmcl.2018.07.018 |
| Escherichia coli |
Escherichia coli |
MIC |
12.5 |
ug.mL-1 |
10.1016/j.bmcl.2018.07.018 |
| Escherichia coli |
Escherichia coli |
MIC |
512.0 |
ug.mL-1 |
10.1128/aac.01337-07 |
| Escherichia coli |
Escherichia coli |
Ratio |
1.0 |
None |
10.1016/j.ejmech.2012.03.008 |
| Escherichia coli |
Escherichia coli |
Ratio |
2.0 |
None |
10.1016/j.ejmech.2012.03.008 |
| Finegoldia magna |
Finegoldia magna |
Activity |
0.0 |
% |
10.1128/aac.00355-08 |
| Finegoldia magna |
Finegoldia magna |
Activity |
97.0 |
% |
10.1128/aac.00355-08 |
| Finegoldia magna |
Finegoldia magna |
MIC |
0.03 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Finegoldia magna |
Finegoldia magna |
MIC50 |
0.5 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Finegoldia magna |
Finegoldia magna |
MIC90 |
8.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Fusobacterium mortiferum |
Fusobacterium mortiferum |
Activity |
0.0 |
% |
10.1128/aac.00355-08 |
| Fusobacterium mortiferum |
Fusobacterium mortiferum |
Activity |
100.0 |
% |
10.1128/aac.00355-08 |
| Fusobacterium mortiferum |
Fusobacterium mortiferum |
MIC |
0.06 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Fusobacterium mortiferum |
Fusobacterium mortiferum |
MIC50 |
1.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Fusobacterium mortiferum |
Fusobacterium mortiferum |
MIC90 |
2.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Fusobacterium necrophorum |
Fusobacterium necrophorum |
Activity |
0.0 |
% |
10.1128/aac.00355-08 |
| Fusobacterium necrophorum |
Fusobacterium necrophorum |
Activity |
100.0 |
% |
10.1128/aac.00355-08 |
| Fusobacterium necrophorum |
Fusobacterium necrophorum |
MIC |
0.06 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Fusobacterium necrophorum |
Fusobacterium necrophorum |
MIC50 |
1.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Fusobacterium necrophorum |
Fusobacterium necrophorum |
MIC90 |
2.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Fusobacterium nucleatum |
Fusobacterium nucleatum |
Activity |
0.0 |
% |
10.1128/aac.00355-08 |
| Fusobacterium nucleatum |
Fusobacterium nucleatum |
Activity |
100.0 |
% |
10.1128/aac.00355-08 |
| Fusobacterium nucleatum |
Fusobacterium nucleatum |
MIC |
0.06 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Fusobacterium nucleatum |
Fusobacterium nucleatum |
MIC50 |
1.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Fusobacterium nucleatum |
Fusobacterium nucleatum |
MIC90 |
2.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Fusobacterium varium |
Fusobacterium varium |
Activity |
0.0 |
% |
10.1128/aac.00355-08 |
| Fusobacterium varium |
Fusobacterium varium |
Activity |
100.0 |
% |
10.1128/aac.00355-08 |
| Fusobacterium varium |
Fusobacterium varium |
MIC |
0.06 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Fusobacterium varium |
Fusobacterium varium |
MIC50 |
1.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Fusobacterium varium |
Fusobacterium varium |
MIC90 |
2.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Inhibition |
nan |
% |
10.1124/dmd.111.041731 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
Inhibition |
nan |
% |
10.1124/dmd.111.041731 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
56234.1 |
nM |
None |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
nan |
None |
None |
| Homo sapiens |
HERG |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
29934.9 |
nM |
None |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
Insulin-degrading enzyme |
IC50 |
7000.0 |
nM |
10.1016/j.ejmech.2019.06.057 |
| Homo sapiens |
Insulin-degrading enzyme |
Inhibition |
68.0 |
% |
10.1016/j.ejmech.2019.06.057 |
| Homo sapiens |
Insulin-degrading enzyme |
Inhibition |
70.0 |
% |
10.1016/j.ejmech.2019.06.057 |
| Homo sapiens |
Insulin-degrading enzyme |
Inhibition |
nan |
% |
10.1016/j.ejmech.2019.06.057 |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
Inhibition |
nan |
% |
10.1124/dmd.111.041731 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Oligopeptide transporter small intestine isoform |
Ki |
28000000.0 |
nM |
10.1016/j.ejpb.2004.07.008 |
| Homo sapiens |
Oligopeptide transporter small intestine isoform |
Ki |
28000000.0 |
nM |
10.1021/jm048982w |
| Homo sapiens |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 |
Potency |
26854.5 |
nM |
None |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Solute carrier family 15 member 2 |
Ki |
4265795.19 |
nM |
10.1016/j.bmc.2011.06.027 |
| Homo sapiens |
Solute carrier family 15 member 2 |
Ki |
4300000.0 |
nM |
10.1016/j.bmc.2011.06.027 |
| Homo sapiens |
Solute carrier family 22 member 8 |
Inhibition |
nan |
% |
10.1124/dmd.112.049569 |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
MIC |
0.39 |
ug.mL-1 |
10.1016/j.bmcl.2018.07.018 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
MIC |
0.78 |
ug.mL-1 |
10.1016/j.bmcl.2018.07.018 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
MIC |
1.56 |
ug.mL-1 |
10.1016/j.bmcl.2018.07.018 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
MIC |
3.13 |
ug.mL-1 |
10.1016/j.bmcl.2018.07.018 |
| Listeria monocytogenes |
Listeria monocytogenes |
IZ |
31.4 |
mm |
10.1128/aac.00503-10 |
| Listeria monocytogenes |
Listeria monocytogenes |
IZ |
34.2 |
mm |
10.1128/aac.00503-10 |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Mus musculus |
Solute carrier family 22 member 6 |
Inhibition |
nan |
% |
10.1124/dmd.112.049569 |
| Mus musculus |
Solute carrier family 22 member 8 |
Drug uptake |
nan |
None |
10.1124/dmd.112.049569 |
| Mus musculus |
Solute carrier family 22 member 8 |
IC50 |
105000.0 |
nM |
10.1124/dmd.112.049569 |
| Mus musculus |
Solute carrier family 22 member 8 |
Inhibition |
nan |
% |
10.1124/dmd.112.049569 |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Parvimonas micra |
Parvimonas micra |
Activity |
0.0 |
% |
10.1128/aac.00355-08 |
| Parvimonas micra |
Parvimonas micra |
Activity |
97.0 |
% |
10.1128/aac.00355-08 |
| Parvimonas micra |
Parvimonas micra |
MIC |
0.03 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Parvimonas micra |
Parvimonas micra |
MIC50 |
0.5 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Parvimonas micra |
Parvimonas micra |
MIC90 |
8.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Peptoniphilus asaccharolyticus |
Peptoniphilus asaccharolyticus |
Activity |
0.0 |
% |
10.1128/aac.00355-08 |
| Peptoniphilus asaccharolyticus |
Peptoniphilus asaccharolyticus |
Activity |
97.0 |
% |
10.1128/aac.00355-08 |
| Peptoniphilus asaccharolyticus |
Peptoniphilus asaccharolyticus |
MIC |
0.03 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Peptoniphilus asaccharolyticus |
Peptoniphilus asaccharolyticus |
MIC50 |
0.5 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Peptoniphilus asaccharolyticus |
Peptoniphilus asaccharolyticus |
MIC90 |
8.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Peptostreptococcus anaerobius |
Peptostreptococcus anaerobius |
Activity |
0.0 |
% |
10.1128/aac.00355-08 |
| Peptostreptococcus anaerobius |
Peptostreptococcus anaerobius |
Activity |
97.0 |
% |
10.1128/aac.00355-08 |
| Peptostreptococcus anaerobius |
Peptostreptococcus anaerobius |
MIC |
0.03 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Peptostreptococcus anaerobius |
Peptostreptococcus anaerobius |
MIC50 |
0.5 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Peptostreptococcus anaerobius |
Peptostreptococcus anaerobius |
MIC90 |
8.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Phocaeicola vulgatus |
Phocaeicola vulgatus |
Activity |
30.0 |
% |
10.1128/aac.00355-08 |
| Phocaeicola vulgatus |
Phocaeicola vulgatus |
Activity |
44.0 |
% |
10.1128/aac.00355-08 |
| Phocaeicola vulgatus |
Phocaeicola vulgatus |
MIC |
4.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Phocaeicola vulgatus |
Phocaeicola vulgatus |
MIC50 |
32.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Phocaeicola vulgatus |
Phocaeicola vulgatus |
MIC90 |
128.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Prevotella bivia |
Prevotella bivia |
Activity |
6.0 |
% |
10.1128/aac.00355-08 |
| Prevotella bivia |
Prevotella bivia |
Activity |
94.0 |
% |
10.1128/aac.00355-08 |
| Prevotella bivia |
Prevotella bivia |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Prevotella bivia |
Prevotella bivia |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Prevotella bivia |
Prevotella bivia |
MIC90 |
8.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Prevotella buccae |
Prevotella buccae |
Activity |
6.0 |
% |
10.1128/aac.00355-08 |
| Prevotella buccae |
Prevotella buccae |
Activity |
94.0 |
% |
10.1128/aac.00355-08 |
| Prevotella buccae |
Prevotella buccae |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Prevotella buccae |
Prevotella buccae |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Prevotella buccae |
Prevotella buccae |
MIC90 |
8.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Prevotella intermedia |
Prevotella intermedia |
Activity |
6.0 |
% |
10.1128/aac.00355-08 |
| Prevotella intermedia |
Prevotella intermedia |
Activity |
94.0 |
% |
10.1128/aac.00355-08 |
| Prevotella intermedia |
Prevotella intermedia |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Prevotella intermedia |
Prevotella intermedia |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Prevotella intermedia |
Prevotella intermedia |
MIC90 |
8.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Prevotella melaninogenica |
Prevotella melaninogenica |
Activity |
6.0 |
% |
10.1128/aac.00355-08 |
| Prevotella melaninogenica |
Prevotella melaninogenica |
Activity |
94.0 |
% |
10.1128/aac.00355-08 |
| Prevotella melaninogenica |
Prevotella melaninogenica |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Prevotella melaninogenica |
Prevotella melaninogenica |
MIC50 |
2.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Prevotella melaninogenica |
Prevotella melaninogenica |
MIC90 |
8.0 |
ug.mL-1 |
10.1128/aac.00355-08 |
| Proteus mirabilis |
Proteus mirabilis |
MIC |
0.39 |
ug.mL-1 |
10.1016/j.bmcl.2018.07.018 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
200.0 |
ug.mL-1 |
10.1016/j.bmcl.2018.07.018 |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Liver |
Drug uptake |
5.1 |
umol/L |
10.1124/dmd.111.042101 |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Oligopeptide transporter, kidney isoform |
Ki |
4300000.0 |
nM |
10.1016/j.ejpb.2004.07.008 |
| Rattus norvegicus |
Plasma |
Fu |
0.738 |
None |
10.1124/dmd.111.042101 |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
21192.3 |
nM |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
26679.5 |
nM |
None |
| Salmonella enterica subsp. enterica serovar Typhimurium |
Salmonella typhimurium |
Ratio |
1.0 |
None |
10.1016/j.ejmech.2012.03.008 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Shigella sonnei |
Shigella sonnei |
Imax |
0.5 |
ug ml-1 |
10.1128/aac.00227-08 |
| Veillonella parvula |
Veillonella parvula |
MIC |
0.25 |
ug.mL-1 |
10.1128/aac.00355-08 |
| None |
ADMET |
CL |
1.5 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
CL |
1.8 |
mL.min-1.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
CL |
3.567 |
mL.min-1.kg-1 |
10.1124/dmd.111.042101 |
| None |
ADMET |
CL |
3.8 |
mL.min-1.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
CL |
5.3 |
mL.min-1.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
CL |
6.217 |
mL.min-1.kg-1 |
10.1124/dmd.111.042101 |
| None |
ADMET |
CL |
40.0 |
mL.min-1.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
MRT |
1.5 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
PPB |
80.65 |
% |
10.6019/CHEMBL3301361 |
| None |
ADMET |
T1/2 |
1.5 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
0.13 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
0.14 |
L.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
Vdss |
0.24 |
L.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
Vdss |
0.49 |
mL/min/kg |
10.1002/jps.20373 |
| None |
Hepatocyte |
Drug uptake |
11.4 |
umol/L |
10.1124/dmd.111.042101 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Index Value |
0.1 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Active |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Marginal |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Index Value |
25.5 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
NON-PROTEIN TARGET |
Fu |
0.15 |
None |
10.1124/dmd.108.020479 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
5.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
9.1 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
No relevant target |
pKa_A1 |
3.37 |
None |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
pKa_A2 |
10.17 |
None |
10.6019/CHEMBL3301361 |
| None |
Unchecked |
Hepatotoxicity (acute) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
Ki |
nan |
None |
None |